Josias Pontes

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Josias Pontes:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 0 11 Aug 2023 Direct
Sigilon Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 0 $0.7500 11 Aug 2023 Direct

Insider Reports Filed by Josias Pontes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588923012126-pontes-josias-2023-08-11 Sigilon Therapeutics, Inc. 11 Aug 2023 2 -$8,075 4 CHIEF FINANCIAL OFFICER 11 Aug 2023, 16:10
/report/000141588923011447-pontes-josias-2023-07-21 Sigilon Therapeutics, Inc. 21 Jul 2023 2 +$27,783 4 CHIEF FINANCIAL OFFICER 24 Jul 2023, 19:45
/report/000141588923003679-pontes-josias-2023-02-28 Sigilon Therapeutics, Inc. 28 Feb 2023 1 $0 4 CHIEF FINANCIAL OFFICER 01 Mar 2023, 15:41
/report/000141588922001634-pontes-josias-2022-02-18 Sigilon Therapeutics, Inc. 18 Feb 2022 1 +$88,800 4 ACTING CHIEF FINANCIAL OFFICE 22 Feb 2022, 16:00
/report/000141588922000197-pontes-josias-2022-01-03 Sigilon Therapeutics, Inc. 03 Jan 2022 1 +$196,950 4 VP, HEAD OF FINANCE 04 Jan 2022, 15:16
/report/000141588921004690-pontes-josias-2021-09-30 Sigilon Therapeutics, Inc. 30 Sep 2021 1 $0 4 VP, HEAD OF FINANCE 04 Oct 2021, 16:15
/report/000141588921003113-pontes-josias-2021-06-14 Sigilon Therapeutics, Inc. 14 Jun 2021 0 $0 3 VP, Head of Finance 21 Jun 2021, 16:20